Literature DB >> 21523926

Cardiometabolic comorbidities and rheumatic diseases: focus on the role of fat mass and adipokines.

Francisca Lago1, Rodolfo Gómez, Javier Conde, Morena Scotece, Juan Jesus Gómez-Reino, Oreste Gualillo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21523926     DOI： 10.1002/acr.20488

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN： 2151-464X            Impact factor:   4.794


× No keyword cloud information.
  10 in total

Review 1.  Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis.

Authors:  DeLisa Fairweather; Michelle A Petri; Michael J Coronado; Leslie T Cooper
Journal:  Expert Rev Clin Immunol       Date:  2012-03       Impact factor: 4.473

Review 2.  What's new in our understanding of the role of adipokines in rheumatic diseases?

Authors:  Rodolfo Gómez; Javier Conde; Morena Scotece; Juan Jesus Gómez-Reino; Francisca Lago; Oreste Gualillo
Journal:  Nat Rev Rheumatol       Date:  2011-08-02       Impact factor: 20.543

3.  Sex differences in assessment of obesity in rheumatoid arthritis.

Authors:  Patricia P Katz; Jinoos Yazdany; Laura Trupin; Gabriela Schmajuk; Mary Margaretten; Jennifer Barton; Lindsey A Criswell; Edward H Yelin
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-01       Impact factor: 4.794

4.  Pathobiology of obesity and osteoarthritis: integrating biomechanics and inflammation.

Authors:  Rita I Issa; Timothy M Griffin
Journal:  Pathobiol Aging Age Relat Dis       Date:  2012-05-09

5.  Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways.

Authors:  Anna Koskinen; Sami Juslin; Riina Nieminen; Teemu Moilanen; Katriina Vuolteenaho; Eeva Moilanen
Journal:  Arthritis Res Ther       Date:  2011-11-11       Impact factor: 5.156

Review 6.  No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biol Rev Camb Philos Soc       Date:  2018-03-25

7.  Statin use and clinical osteoarthritis in the general population: a longitudinal study.

Authors:  U T Kadam; M Blagojevic; J Belcher
Journal:  J Gen Intern Med       Date:  2013-03-08       Impact factor: 5.128

Review 8.  Adipokines, metabolic syndrome and rheumatic diseases.

Authors:  Vanessa Abella; Morena Scotece; Javier Conde; Verónica López; Verónica Lazzaro; Jesús Pino; Juan J Gómez-Reino; Oreste Gualillo
Journal:  J Immunol Res       Date:  2014-02-26       Impact factor: 4.818

9.  Metabolic syndrome as a risk factor for total hip or knee replacement due to primary osteoarthritis: a prospective cohort study (the HUNT study and the Norwegian Arthroplasty Register).

Authors:  Alf Inge Hellevik; Marianne Bakke Johnsen; Arnulf Langhammer; Valborg Baste; Ove Furnes; Kjersti Storheim; John Anker Zwart; Gunnar Birkeland Flugsrud; Lars Nordsletten
Journal:  Clin Epidemiol       Date:  2018-01-10       Impact factor: 4.790

10.  Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis.

Authors:  Elinoar Hoffman; Michal A Rahat; Joy Feld; Muna Elias; Itzhak Rosner; Lisa Kaly; Idit Lavie; Tal Gazitt; Devy Zisman
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.